Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Encarnacion JA, Coll E, Manso C, Llorente S, Morales F, Saura I, Lopez-Cubillana P, Martinez-Valls PLG, Martinez G, De la Fuente I, Cardenas E, Alonso-Romero JL, Ruiz P, Moya J, Dominguez-Gil B, Royo-Villanova M. Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Med Sci (Basel). 2025 Sep 14;13(3):188. doi: 10.3390/medsci13030188. PubMed PMID: 40981187; PubMed Central PMCID: PMC12452455.
AÑO: 2025; IF: 4.4
40981187
Encarnacion JA, Morillo Macias V, De la Fuente Munoz I, Soria VD, Fernandez Fornos L, Antequera MA, Rey OA, Garcia Martinez V, Alonso-Romero JL, Garcia Gomez R. Apalutamide and Stereotactic Body Radiotherapy in Metastatic Hormone-Sensitive Prostate Cancer: Multicenter Real-World Study. Cancers (Basel). 2025 Jul 2;17(13):2216. doi: 10.3390/cancers17132216. PubMed PMID: 40647514; PubMed Central PMCID: PMC12249003.
AÑO: 2025; IF: 4.4
40647514
Encarnación J.A., Hernández A.L., López G.L., Alonso-Romero J.L., De la Fuente Muñoz M.I., Cánovas E.C., Carreño P.R., Royo-Villanova M., Manso C. Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin—a case report. Journal of Medical Case Reports. December 2025. 19. 10.1186/s13256-025-05402-z
AÑO: 2025; IF: 0.8
40676639
Asensio Lopez MDC, Ruiz Ballester M, Bastida Nicolas FJ, Soler Pardo F, Alonso-Romero JL, Caro-Martinez C, Pascual Figal D, Lax A. miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation. Int J Mol Sci. 2025 Oct 14;26(20):10002. doi: 10.3390/ijms262010002. PubMed PMID: 41155295; PubMed Central PMCID: PMC12562630.
AÑO: 2025; IF: 4.9
41155295
López-Miranda E., Pérez-García J.M., Gión M., Ribelles N., Cortez-Castedo P., Alonso-Romero J.L., García M.M., González-Santiago S., Bermejo B., Morales S., Carañana V., Garrigós L., Fernández-Pinto M., García-Vicente S., Garcia-Sanz A., Mena-Molina A., Boix O., Alcalá-López D., Llombart-Cussac A., Cortés J. Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial. Breast Cancer Research. December 2025. 27. 10.1186/s13058-025-02089-4
AÑO: 2025; IF: 5.6
40770648
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL